Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.
about
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Ethinylestradiol-chlormadinone ...... ation of the metabolic impact.
@en
Ethinylestradiol-chlormadinone ...... ation of the metabolic impact.
@nl
type
label
Ethinylestradiol-chlormadinone ...... ation of the metabolic impact.
@en
Ethinylestradiol-chlormadinone ...... ation of the metabolic impact.
@nl
prefLabel
Ethinylestradiol-chlormadinone ...... ation of the metabolic impact.
@en
Ethinylestradiol-chlormadinone ...... ation of the metabolic impact.
@nl
P2093
P2860
P356
P1476
Ethinylestradiol-chlormadinone ...... ation of the metabolic impact.
@en
P2093
Alessandro Bompiani
Antonio Lanzone
Daniela Romualdi
Giuseppe Campagna
Luigi Ricciardi
Maurizio Guido
P2860
P304
P356
10.1177/1933719110371515
P577
2010-08-01T00:00:00Z